A carregar...

Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment

This Review discusses the various types of non-coding oligonucleotides, which have garnered extensive interest as new alternatives for targeted cancer therapies over small molecule inhibitors and monoclonal antibodies. These oligonucleotides can target any hallmark of cancer, no longer limited to so...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Treat Rev
Main Authors: Ngamcherdtrakul, Worapol, Castro, David J., Gu, Shenda, Morry, Jingga, Reda, Moataz, Gray, Joe W., Yantasee, Wassana
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826844/
https://ncbi.nlm.nih.gov/pubmed/26930249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2016.02.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!